Skip to main content
. 2014 May 24;44(6):813–821. doi: 10.1111/cea.12269

Table 2.

Sputum cells during exacerbations

No exacerbation (Asthma Index 0–29) Exacerbation (Asthma Index ≥ 30) Combined
Acute Baseline Acute Baseline Acute Baseline
Eosinophil (Total) 0.1 (0.0–0.2) 0.0 (0.0–0.1) 0.1a (0.0–0.4) 0.0 (0.0–0.1) 0.1 (0.0–0.3) 0.0 (0.0–0.1)
Eosinophil, % 0.5 (0.2–2.1) 0.3 (0.0–1.3) 0.5 (0.2–1.4) 0.3 (0.0–0.5) 0.5 (0.3–2.0) 0.3 (0.0–0.8)
Neutrophil (Total) 1.9 (0.8–4.6) 2.2 (1.0–3.9) 7.6a (3.2–25.6) 1.6 (0.5–3.6) 4.3 (1.2–8.7) 2.0 (0.7–3.8)
Neutrophil, % 32.0 (17.4–45.6) 31.3 (17.0–43.0) 49.8a (39.4–73.9) 31.4 (18.9–50.2) 43.1 (24–68.5) 31.4 (17.0–46.7)
Lymphocyte (Total) 0.1 (0.1–0.3) 0.2 (0.0–0.4) 0.4 (0.1–1.9) 0.2 (0.1–0.3) 0.3 (0.1–0.5) 0.2 (0.1–0.3)
Lymphocytes, % 2.5 (1.6–3.6) 3.0 (0.9–5.5) 2.9 (1.8–3.8) 3.0 (1.8–4.7) 2.7 (2.0–3.7) 3.0 (1.5–5.0)
Macrophage (Total) 4.3 (2.6–6.2) 4.9 (2.3–7.6) 4.3 (2.2–16.8) 3.8 (2.5–6.1) 4.3 (2.6–8.6) 4.2 (2.5–6.5)
Macrophage, % 65.0 (50.9–76.6) 65.5 (51.9–80.0) 43.5a (22.8–55.9) 63.9 (44.2–73.0) 53.1 (26.5–71.0) 64.5 (46.2–74.8)

Counts for the respective cell types are shown as total cells (number of cells ×105 per gram of sputum) or as percentage of white blood cells in sputum. Values are medians with interquartile range.

a

Represents a P < 0.05 in the difference between acute and baseline visits within the group.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.